View More Recent Stories
-
Rapport Therapeutics (RAPP) Appoints Jeffrey Sevigny as Chief Medical Officer
-
TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
-
Jones Trading Starts Rapport Therapeutics (RAPP) at Buy
-
Stifel Reiterates Buy Rating on Rapport Therapeutics (RAPP)
-
TD Cowen Starts Rapport Therapeutics (RAPP) at Buy
-
Stifel Starts Rapport Therapeutics (RAPP) at Buy
-
Jefferies Starts Rapport Therapeutics (RAPP) at Buy


